June 20, 2026 — RNews

#pharmacotherapy — Saturday, June 20, 2026 (1 items)

hot top new

← prev day next day →

0

Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial. (linkinghub.elsevier.com)

Davies MJ … Sjostrom CD The Lancet 2026-06-20

#clinical trial #metabolic syndrome #pharmacotherapy #obesity #glp-1